Dr. Hao Phan | Cardiovascular Medicine | Best Researcher Award 

Lecturer | Pham Ngoc Thach University of Medicine | Vietnam

Dr. Hao Thai Phan is an emerging medical researcher affiliated with the University of Medicine and Pharmacy, Hue University, Viet Nam, whose work reflects a focused commitment to advancing diagnostic science and improving clinical outcomes, particularly in the field of nephrology and cardiorenal interactions. With a developing but impactful research portfolio, he has contributed three peer-reviewed publications that have collectively earned 15 citations, demonstrating growing recognition of his scholarly work within the international medical community. His notable study on the diagnostic value of plasma NGAL in cardiorenal syndrome type 1, published in the Electronic Journal of General Medicine, highlights his expertise in utilizing novel biomarkers to enhance early detection and management of complex cardiorenal conditions. Dr. Phan’s research interests span clinical diagnostics, internal medicine, and interdisciplinary approaches to kidney–heart pathophysiology, as reflected in collaborations with nine co-authors from diverse medical specialties. His work aligns with global efforts to strengthen evidence-based practice in low- and middle-income healthcare settings, focusing on improving accessibility to reliable diagnostic tools and elevating patient care standards. Although early in his academic career, he has begun to establish a foundation for long-term contributions to translational research, integrating laboratory insights with real-world clinical needs. His engagement with collaborative networks further reinforces his role as a developing scholar dedicated to addressing critical health challenges in Viet Nam and beyond. Through his growing publication record, commitment to biomarker research, and interdisciplinary partnerships, Dr. Phan is progressively shaping a research trajectory that supports enhanced clinical decision-making, fosters innovation in disease detection, and contributes to the broader scientific mission of improving health outcomes across the Asia-Pacific region.

1. Huynh, P. K., Setty, A., Phan, H., & Le, T. Q. (2021). Probabilistic domain-knowledge modeling of disorder pathogenesis for dynamics forecasting of acute onset. Artificial Intelligence in Medicine, 115, 102056.
Cited by: 20

2. Phan, H. T., Hoang Bui, B., Hoang Anh, T., & Huynh Van, M. (2020). Value of plasma NGAL and creatinine on first day of admission in the diagnosis of cardiorenal syndrome type 1. Cardiology Research and Practice, 2020(1), 2789410.
Cited by: 15

3. Hanh, D. L. M., Hao, P. T., & Tho, N. V. (2023). Risk factors related to the death of admitted COVID-19 patients: A Buffalo study. The Open Respiratory Medicine Journal, 17, e187430642302200.
Cited by: 4

4. Phan, T. H., Phan, D. Q., Nguyễn, V. T., & Phan, M. H. (2022). Đặc điểm lâm sàng, cận lâm sàng BN COVID-19 nhập viện. Tạp chí Y học Việt Nam, 517(1).
Cited by: 3

5. Phan, H. T. (2018). Non-compaction cardiomyopathy misdiagnosed as dilated cardiomyopathy. Journal of Case Reports, 8(1), 10–13.
Cited by: 3

Dr. Hao Thai Phan’s research advances early diagnostics in critical care by improving biomarker-based detection of cardiorenal syndrome, enabling faster and more accurate clinical decision-making. His work contributes to strengthening patient outcomes in resource-limited settings and supports global innovation in precision medicine and acute care management.

Hao Phan | Cardiovascular Medicine | Best Researcher Award

You May Also Like